» Articles » PMID: 27527585

Prenatal Kynurenine Exposure in Rats: Age-dependent Changes in NMDA Receptor Expression and Conditioned Fear Responding

Overview
Specialty Pharmacology
Date 2016 Aug 17
PMID 27527585
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Levels of kynurenic acid (KYNA), an endogenous negative modulator of alpha 7 nicotinic acetylcholine receptors (α7nAChRs) and antagonist at glutamatergic N-methyl-D-aspartate receptors (NMDARs), are elevated in the brain of patients with schizophrenia (SZ). In rats, dietary exposure to KYNA's immediate precursor kynurenine during the last week of gestation produces neurochemical and cognitive deficits in adulthood that resemble those seen in patients with SZ.

Objectives: The present experiments examined whether prenatal kynurenine exposure results in age-dependent changes in the kynurenine pathway (KP), expression of selected receptors, and cognitive function.

Methods: Pregnant dams were fed unadulterated mash (progeny = ECON) or mash containing kynurenine (100 mg/day; progeny = EKYN) from embryonic day (ED) 15 to 22. Male offspring were assessed as juveniles, i.e., prior to puberty (postnatal day [PD] 32), or as adults (PD70) for brain KYNA levels, α7nAChR and NMDAR gene expression, and performance on a trace fear conditioning (TFC) task.

Results: KYNA levels were comparable between juvenile ECON and EKYN rats, whereas EKYN adults exhibited a ~3-fold increase in brain KYNA relative to ECONs. NR2A expression was persistently reduced (30-40 %) in EKYN rats at both ages. Compared to ECON adults, there was a 50 % reduction in NR1, and a trend toward decreased α7nAChR expression, in adult EKYN rats. Surprisingly, juvenile EKYN rats performed significantly better in the TFC paradigm than controls, whereas adult EKYN animals showed the predicted deficits.

Conclusions: Collectively, our results provide evidence that KP changes in the fetal brain alter neuronal development and cause age-dependent effects on neurochemistry and cognitive performance.

Citing Articles

Does the kynurenine pathway play a pathogenic role in autism spectrum disorder?.

Santana-Coelho D Brain Behav Immun Health. 2024; 40:100839.

PMID: 39263315 PMC: 11387593. DOI: 10.1016/j.bbih.2024.100839.


Developmental Exposure to Kynurenine Affects Zebrafish and Rat Behavior.

Marszalek-Grabska M, Gawel K, Kosheva N, Kocki T, Turski W Cells. 2023; 12(18).

PMID: 37759447 PMC: 10526278. DOI: 10.3390/cells12182224.


Activated Tryptophan-Kynurenine metabolic system in the human brain is associated with learned fear.

Battaglia M, Di Fazio C, Battaglia S Front Mol Neurosci. 2023; 16:1217090.

PMID: 37575966 PMC: 10416643. DOI: 10.3389/fnmol.2023.1217090.


Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder.

Murakami Y, Imamura Y, Kasahara Y, Yoshida C, Momono Y, Fang K Cells. 2023; 12(7).

PMID: 37048160 PMC: 10093447. DOI: 10.3390/cells12071087.


Kynurenine aminotransferase II inhibition promotes sleep and rescues impairments induced by neurodevelopmental insult.

Milosavljevic S, Smith A, Wright C, Valafar H, Pocivavsek A Transl Psychiatry. 2023; 13(1):106.

PMID: 37002202 PMC: 10066394. DOI: 10.1038/s41398-023-02399-1.


References
1.
Rao P, Kumar R, Farkhondeh M, Baskerville S, Lodish H . Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A. 2006; 103(23):8721-6. PMC: 1482645. DOI: 10.1073/pnas.0602831103. View

2.
Waters F, Maybery M, Badcock J, Michie P . Context memory and binding in schizophrenia. Schizophr Res. 2004; 68(2-3):119-25. DOI: 10.1016/S0920-9964(03)00221-4. View

3.
Wonodi I, Stine O, Sathyasaikumar K, Roberts R, Mitchell B, Hong L . Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatry. 2011; 68(7):665-74. PMC: 3855543. DOI: 10.1001/archgenpsychiatry.2011.71. View

4.
Gilmartin M, Balderston N, Helmstetter F . Prefrontal cortical regulation of fear learning. Trends Neurosci. 2014; 37(8):455-64. PMC: 4119830. DOI: 10.1016/j.tins.2014.05.004. View

5.
Brebion G, David A, Jones H, Ohlsen R, Pilowsky L . Temporal context discrimination in patients with schizophrenia: associations with auditory hallucinations and negative symptoms. Neuropsychologia. 2006; 45(4):817-23. DOI: 10.1016/j.neuropsychologia.2006.08.009. View